Company Filing History:
Years Active: 2014-2017
Title: The Innovations of Inventor Johan Peränen in Neuroscience
Introduction: Johan Peränen is a notable inventor based in Helsinki, Finland, renowned for his contributions to the field of neuroscience. With a total of two patents to his name, Peränen is making significant strides in the treatment of neuronal disorders through innovative pharmaceutical compounds. His work has garnered attention and respect within the scientific community.
Latest Patents: Peränen's latest inventions focus on the neurotrophic factor MANF (Mesencephalic Astrocyte-Derived Neurotrophic Factor). His patents address treatment options for a range of neuronal disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, drug addiction, and ischemic brain injury. These patents present pharmaceutical compounds comprising MANF nucleic acid molecules, proteins, or functional fragments intended for therapeutic use in alleviating peripheral neuropathies.
Career Highlights: Johan Peränen is currently associated with Herantis Pharma Plc, a biopharmaceutical company specializing in the development of innovative treatments for brain disorders. His work at Herantis Pharma has positioned him among the leading inventors in the field of neurobiology, allowing him to contribute to groundbreaking research and development efforts.
Collaborations: Peränen collaborates closely with esteemed colleagues, including Mart Saarma and Merja Voutilainen. Together, they work on advancing the understanding and treatment of neurodegenerative diseases, leveraging their combined expertise to push the boundaries of current medical knowledge.
Conclusion: As an inventor, Johan Peränen is making remarkable contributions to the field of neuroscience through his innovative patents. His research not only seeks to enhance the treatment of complex neuronal disorders but also reflects a commitment to improving the quality of life for individuals affected by such conditions. Through his work at Herantis Pharma and collaborations with distinguished researchers, Peränen continues to pave the way for future innovations in healthcare.